Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Lager risico op abnormaal uterien bloedverlies met dabigatran ten opzichte van warfarine
jan 2017